Lepirudin
From Wikipedia, the free encyclopedia
Image:Lepirudin.png | |
Lepirudin
|
|
Systematic (IUPAC) name | |
? | |
Identifiers | |
CAS number | 120993-53-5 |
ATC code | B01AE02 |
PubChem | ? |
DrugBank | BTD00024 |
Chemical data | |
Formula | C288H448N80O110S6 |
Mol. weight | 6983.5 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ~1.3 hours |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Lepirudin (Refludan ®) is an anticoagulant which functions as a direct thrombin inhibitor.
[edit] External links
- DDB 30082
- Smythe M, Stephens J, Koerber J, Mattson J (2005). "A comparison of lepirudin and argatroban outcomes.". Clin Appl Thromb Hemost 11 (4): 371-4. PMID 16244762.
- "Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin.". Blood. PMID 16690967.
- Lubenow N, Eichler P, Lietz T, Greinacher A (2005). "Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3.". J Thromb Haemost 3 (11): 2428-36. PMID 16241940.